RARE alert: Shire's next deal could be "transformational"

It's Budget day (here in the UK), so here is a piece of RARE that is completely unconnected to one of the busiest days in financial/political journalism.

I hear Shire's next deal is likely to be "transformational".

Since Flemming Ornskov took the helm of pharmaceutical giant he has carried out quite a few major deals, such as this year's $5.2 billion acquisition of NPS or the $4.2 billion purchase of ViroPharma in 2013...

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Wednesday, 18 March 2015, 5:17 pm

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation